Trial Profile
A multicentre study to compare the efficacy and safety of infliximab versus adalimumab in patients with refractory uveitis due to Behçet's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Behcet's syndrome
- Focus Therapeutic Use
- 22 Jun 2015 New trial record